JP4272100B2 - Cosmetics that improve dullness - Google Patents

Description

  The present invention relates to a cosmetic, and more particularly to a cosmetic useful for improving dullness.

  In the field of cosmetics, “dullness” is a phenomenon that appears with age and is one of the phenomena whose cause has not been elucidated. So-called dullness is a phenomenon that appears in a specific area of the face rather than the entire face, such as around the eyes, and looks darker and lighter in appearance, and correlates with age as described above. It appears as a phenomenon that makes people aware of age. Since “dullness” is easily observed visually, this countermeasure has been desired. The cause of dullness is, for example, the theory that light transmittance decreases due to denaturation of stratum corneum cells with light, and the protein itself is also denatured and yellowish, resulting in dullness (see, for example, Patent Document 1). See), the water retention function of the stratum corneum is reduced, the transparency of the stratum corneum is lowered, the surface shape is wrinkled, and the intensity of scattered light on the skin surface is impaired (for example, Patent Document 2) In addition to the decrease in the intensity of the scattered light, the amount of melanin accumulated in the stratum corneum increases and the permeability is impaired (see, for example, Patent Document 3) or melanin There is a theory that the skin surface hue is caused by non-uniformity of the granule distribution and micro blood flow distribution (see, for example, Patent Document 4). There are different ways to deal with these phenomena that are considered to be the cause. For example, if the stratum corneum is denatured, it may be possible to remove old stratum corneum cells using a release agent for stratum corneum. If it is due to the shape of the skin surface, a moisturizer can be administered. If melanin is accumulated, treatment with a melanin production inhibitor is effective. If the blood flow is uneven, a blood flow improver. It is thought that the treatment by is effective. Actually, all of these have moderate effects, and it is conceivable that “dullness” generation is caused by a combination of various causes. Therefore, even if a certain degree of improvement is certainly recognized only by solving each cause, the present situation is that the cosmetic user is not satisfied.

On the other hand, hesperidin such as hesperidin and α-glycosyl hesperidin and / or glycoside thereof has an effect of promoting metabolism (for example, see Patent Document 5) and an effect of improving blood flow (for example, see Patent Document 6). ) to the like are known, the extract Asian ginseng improves blood flow, that is known to reside protective effect against ischemia (e.g., see non-Patent Document 1). However, it is not known to use both at the same time for the purpose of improving the dullness of the skin.

JP 2002-338426 A JP 2002-53422 A JP 2001-158730 A Japanese Patent Laid-Open No. 10-25236 JP 2004-75550 A JP 2004-35440 A Eun-Kyung Park et.al., Biol.Pharm.Bull., 27 (3), 433-436 (2004)

  The present invention has been made under such circumstances, and an object of the present invention is to provide a cosmetic excellent in dullness improvement effect.

In view of such a situation, the present inventors have sought for cosmetics having an excellent effect of improving dullness, and as a result of intensive research efforts, 1) ginsenoside 0. And 01 to 0.05 wt%, 2) Hesuperiji down glycosides 0.0001 wt% and cosmetics containing the heading that has such properties, thereby completing the invention It came to. That is, this invention relates to the technique shown below.
(1) 1) 0.01 to 0.5 wt% ginsenoside and, 2) Hesuperiji down glycosides 0.0001 wt% and cosmetics containing the.
(2) The cosmetic according to (1), wherein the ginsenoside is contained as a hydroalcoholic extract of a root part of Panax ginseng.
(3) glycoside of the Hesuperiji down, characterized in that it is α- glycosyl hesperidin, cosmetic according to (1) or (2).
(4) The cosmetic according to any one of (1) to (3), further comprising 1 μM to 1000 μM of astilbine.
(5) The cosmetic according to (4), characterized in that it contains the astilbine as an alcoholic extract of walnut family Enki (Engelhardtiachrisolepis) leaves.
(6) The cosmetic according to any one of (1) to (5), further comprising 0.1 to 10 μM betulinic acid and / or a salt thereof.
(7) The cosmetic according to (6), wherein the betulinic acid and / or a salt thereof is contained as a hydrous alcoholic extract of Betula japonica.
(8) The cosmetic according to any one of (1) to (7), which has a dullness improving effect.

  ADVANTAGE OF THE INVENTION According to this invention, the cosmetics excellent in the dullness improvement effect can be provided.

(1) Ginsenoside which is an essential component of the cosmetic of the present invention The cosmetic of the present invention contains 0.01 to 0.5% by mass, more preferably 0.02 to 0.1% by mass of ginsenoside as an essential component. It is characterized by doing. Here, ginsenoside is a general term for terpene glycosides contained in the root of ginseng ginseng. For example, ginsenoside Rg1, ginsenoside Rg2, ginsenoside Rg3, ginsenoside Rh1, ginsenoside Rh2, etc. are known as representative ones. Yes. Such ginsenosides usually contain about 0.1 to 0.5% by mass in the residue in a state where water extraction is performed and the solvent is removed. Moreover, when extracting only with alcohol, such as ethanol, 1-4 mass% is contained in the residue which removed the solvent. When an alcohol water mixing medium such as an ethanol aqueous solution is used, 30 to 60% by mass is contained in the residue from which the solvent has been removed. A particularly preferred hydroalcoholic solvent mixture is a 75-85% aqueous ethanol solution. The content of ginsenoside can be quantified by high performance liquid chromatography using an amino group-modified silica column. The quantification may be performed by comparing with a standard sample, and the conditions for high performance liquid chromatography are preferably 95% acetonitrile aqueous solution for the mobile phase. Detection is preferably performed by absorption in the ultraviolet region of 210 nm. To extract ginsenoside from ginseng, the root of ginseng is shredded, 1 to 10 times the amount of solvent is added, and it is immersed for several days at room temperature or for several hours under warming conditions. After the immersion, insoluble matters are removed by filtration as necessary, and the solvent may be removed by distillation under reduced pressure or freeze drying. A production example is shown below. In the cosmetics of the present invention, such ginsenoside works with hesperidin and its glycosides described later to improve local blood flow, regulate the skin microstructure, and inhibit the production of melanin pigments. Exhibits the effect of improving dullness.

<Production Example 1>
1 kg of dried ginseng root was chopped, 10 l of water was added thereto, and the mixture was heated at 90 ° C. for 4 hours. Insolubles were removed by filtration and lyophilized to obtain 0.98 g of amorphous. When this product was analyzed under the above-mentioned high performance liquid chromatography conditions, it contained 0.3% by mass of ginsenoside Rg2. (Extract 1)

<Production Example 2>
The extraction solvent of Production Example 1 was changed to a 75% ethanol aqueous solution, the concentration was distilled off under reduced pressure, and then the combination was changed to a freeze-drying combination. The same study was conducted, and an amorphous material containing 46% by mass of ginsenoside Rg2 was obtained. 56 g was obtained. (Extract 2)

<Production Example 3>
The extraction solvent of Production Example 1 was changed to ethanol and the concentration was changed to distillation under reduced pressure, and the same examination was performed to obtain 1.12 g of amorphous containing 1.1% by mass of ginsenoside Rg2. (Extract 3)

(2) The cosmetic of the cosmetic of the essential components Hesuperiji down glycosides present invention of the present invention, alpha - characterized in that it contains the glycoside of Hesuperiji emissions such as glycosyl hesperidin. The glycosides Hesuperiji down, For example, alpha - glycosyl hesperidin, alpha-mannosyl hesperidin like. Hesperidin is a heparetin rutinose glycoside, which is a flavanone, also called vitamin P. Hesperidin is present in the peel of citrus fruits and is obtained by extraction. Α-glycosyl hesperidin can be obtained by glycosylating such hesperidin using an enzyme such as glucosidase. Regarding α-glycosyl hesperidin, a commercial product already exists, and it is also possible in the present invention to purchase and use such a commercial product. Among these commercially available products, α-glucosyl hesperidin sold by Ezaki Glico Co., Ltd. or Toyo Seika Co., Ltd. is particularly preferable. In the cosmetic of the present invention, glycosides such Hesuperiji down is worked together with the ginsenoside, thereby improving blood flow locally, trimmed the microstructure of the skin, and, by inhibiting the production of melanin pigment Exhibits the effect of improving dullness. To exhibit such effects, glycosides of the Hesuperiji emissions is also to be able to contain only species, it may also be contained in combination of two or more. To exhibit such effects, a glycoside of such Hesuperiji down, in total, relative to the total amount of the cosmetic, 0.0001% by weight, more preferably 0.0005 to 0.02 It is preferable to contain by mass.

(3) The cosmetic of the cosmetic of the Invention The present invention 1) and 0.01 to 0.5 wt% Ginsenoside, 2) containing a glycoside 0.0001 wt% of Hesuperiji down It is characterized by that. In addition, the combination of these components has the effect of improving the dullness by improving the local blood flow, adjusting the fine structure of the skin, and inhibiting the production of melanin pigment. Thereby, since the element of a dullness can be improved in many ways, it has the dullness improvement effect excellent compared with the conventional cosmetics.

  In addition to these essential components, the cosmetic of the present invention can contain components having a favorable effect on dullness. Preferred examples of such a component that exhibits a favorable effect on dullness include astilbine that suppresses inflammation and adjusts the properties of the skin by moisturizing, betulinic acid having a nonuniformity-improving action, and / or a salt thereof.

  Astilbin is preferably contained in an amount of 1 μM to 1000 μM in terms of effect and stability of the system, and in order to contain such an amount, the alcohol of walnut (Engelhardtiachrisolepis) leaves, preferably a large amount It is preferable to contain it as a monohydric alcohol, particularly preferably 1,3-butanediol extract. This is because when Koki leaves are extracted with water or the like, such components are hardly extracted. Below, the manufacture example of an extract is shown.

<Production Example 4>
1 Kg of dried koki leaves were chopped, 10 l of water was added thereto, and the mixture was heated at 90 ° C. for 4 hours. Insoluble matter was removed by filtration and freeze-dried to obtain 3.1 g of amorphous. (Extract 4) 0.1 g of this product was taken, diluted to 100 ml with water, and analyzed by high performance liquid chromatography. As a result, 0.2 μM astilbine was contained.
Conditions of high performance liquid chromatography; mobile phase: 98% acetonitrile aqueous solution, column NH2-modified silica gel packed column 4.6 × 250 mm, detection: ultraviolet part 256 nm, column temperature: 40 ° C., flow rate 1 ml / min

<Production Example 5>
1 Kg of dried Koki leaves were chopped, 10 L of 50% ethanol aqueous solution was added thereto, and the mixture was heated at 90 ° C. for 4 hours. Insolubles were removed by filtration and lyophilized to obtain 7.3 g of amorphous. (Extract 5) 0.1 g of this product was taken, diluted to 100 ml with water, and analyzed by the high performance liquid chromatography. As a result, 0.7 μM astilbine was contained.

<Production Example 6>
1 Kg of dried koki leaves were chopped, 10 l of 1,3-butanediol was added thereto, and the mixture was heated at 90 ° C. for 4 hours. Insoluble material was removed by filtration and 9.8 l of solution was recovered. (Extract 6) 0.1 g of this product was taken, diluted to 100 ml with water, and analyzed by the above-mentioned high performance liquid chromatography. As a result, it contained 1.8 μM astilbine.

  It is preferable that betulinic acid and / or a salt thereof is contained in an amount of 0.1 to 10 μM, more preferably 0.5 to 1 μM, from the viewpoints of effects and system stability. As a base source of betulinic acid and / or a salt thereof, it is preferable to extract a bark of a birch plant with a hydrous alcohol and use such an extract. Examples of birch plants that can be used to make such an extract include birch and date birch, but birch is particularly preferred. This is because it is appropriate to extract birch bark with hydrous alcohol to achieve the above-mentioned concentration range. Examples of the alcohol that can be used for such extraction include water-containing monohydric alcohols such as water-containing ethanol, water-containing propylene glycol, water-containing polyhydric alcohols such as water-containing 1,3-butanediol, and water-containing polyhydric alcohols are particularly preferable. Of these, hydrous 1,3-butanediol is particularly preferred. Particularly preferred is an aqueous solution of 20 to 40% by mass of 1,3-butanediol.

<Production Example 7>
1 kg of dried birch bark was chopped, 10 l of water was added thereto, and the mixture was heated at 90 ° C. for 4 hours. Insoluble matter was removed by filtration and lyophilized to obtain 1.1 g of amorphous. (Extract 7) 0.1 g of this product was taken, diluted to 100 ml with water, and analyzed by high performance liquid chromatography. As a result, the peak of betulinic acid could not be confirmed.
Conditions of high performance liquid chromatography; mobile phase: 60 mM acetonitrile 0.1 mM phosphate buffer solution (pH 7.0) with 0.1 mM tetrabutylammonium phosphate, column ODS packed column 4.6 × 150 mm, detection: refractive index, Column temperature: 40 ° C., flow rate 1 ml / min

<Production Example 8>
1 kg of dried birch bark was chopped, 10 l of 1,3-butanediol containing 70% by mass of water was added thereto, and the mixture was heated at 90 ° C. for 4 hours. Insoluble matter was removed by filtration and lyophilized to obtain 1.1 g of amorphous. (Extract 7) 0.1 g of this product was taken, diluted to 100 ml with water, and analyzed by high performance liquid chromatography. The concentration of betulinic acid was 0.8 μM.

  In addition to the above-described components, the cosmetic of the present invention can contain optional components usually used in cosmetics within a range that does not impair the effects of the present invention. Such optional ingredients include, for example, macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil Oils such as hardened oil, mole, hardened castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, waxes, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum , Hydrocarbons such as microcrystalline wax, higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid, cetyl alcohol, stearyl alcohol, isostearyl Alcohol, behenyl alcohol, octyldodecanol, higher alcohol such as myristyl alcohol, cetostearyl alcohol, cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate, dimethylpolysiloxane, methylphenylpoly Loxane, linear polysiloxane such as diphenylpolysiloxane, cyclic polysiloxane such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane, amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Oil agents such as silicone oil such as modified polysiloxane such as fluorine-modified polysiloxane, anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, triethanolamine ether of alkyl sulfate, chloride Cationic surfactants such as stearyltrimethylammonium, benzalkonium chloride, laurylamine oxide, imidazoline-based amphoteric surfactants (2-cocoyl-2-imida Zolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), amphoteric surfactants such as acylmethyltaurine, sorbitan fatty acid esters (sorbitan) Monostearate, sorbitan sesquioleate, etc.), glycerin fatty acids (glyceryl monostearate, etc.), propylene glycol fatty acid esters (propylene glycol monostearate, etc.), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid ester Tells (POE-glycerol monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonylphenyl) Ethers, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), Nonionic surfactants such as sucrose fatty acid ester and alkyl glucoside, polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene Polyols such as recall, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexylene glycol, 1,2-hexanediol, 1,2-octanediol, pyrrolidone carboxylic acid Moisturizing ingredients such as sodium, lactic acid, sodium lactate, guar gum, quince seed, carrageenan, galactan, gum arabic, pectin, mannan, starch, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, chondroitin sulfate , Dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, mucoitin sulfate, hyaluronan Droxyethyl guar gum, carboxymethyl guar gum, dextran, keratosulfuric acid, locust bean gum, succinoglucan, caronic acid, chitin, chitosan, carboxymethylchitin, agar, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, sodium polyacrylate, Thickeners such as polyethylene glycol and bentonite, surface may be treated, powder such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, silicic anhydride (silica), aluminum oxide, barium sulfate The surface may be treated, bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide inorganic pigments, the surface may be treated, mica titanium, Fish phosphorus foil, bismuth oxychloride Pearl agents, which may be raked Red 202, Red 228, Red 226, Yellow 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201 No., Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204, and the like, polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer Organic powders such as paraaminobenzoic acid UV absorbers, anthranilic acid UV absorbers, salicylic acid UV absorbers, cinnamic acid UV absorbers, benzophenone UV absorbers, sugar UV absorbers, 2- ( 2′-hydroxy-5′-t-octylphenyl) benzotriazole, 4-methoxy-4′-t-butyldibenzoylmethane, etc. External line absorbers, lower alcohols such as ethanol and isopropanol, vitamin A or its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or its derivatives, vitamin B12, vitamin B15 or its derivatives, etc. Vitamin E such as vitamin B, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone, and the like can be preferably exemplified . It can manufacture by processing these components according to a conventional method. The cosmetic composition of the present invention thus obtained has characteristics that are excellent in improving dullness.

  Hereinafter, the present invention will be described in more detail with reference to examples, but it is needless to say that the present invention is not limited to such examples.

According to the prescription shown below, the emulsion 1 which is the cosmetic of the present invention was produced. That is, the components of A, B, and C are heated to 80 ° C., and gradually added to B under stirring. After that, the mixture is neutralized by adding C, and the particles are prepared with a homogenizer and then cooled with stirring. A milky lotion 1 was obtained. About this, the dullness improvement effect was examined together with Comparative Example 1 in which the α-glycosyl hesperidin aqueous solution was replaced with the extract 2 and Comparative Example 2 in which the extract 2 was replaced with the α-glycosyl hesperidin aqueous solution. In other words, a group of 10 people who are worried about dullness, gathering a total of 30 people, taking a face photo, taking it into an image, converting it to a black and white image, and then converting the brightness of 300 pixels randomly extracted Conversion was made to a value of 0 (totally black) to 100 (totally white), the average value and variation were determined, and the groups were divided so that the average and variation of brightness for each group were comparable. Then, one group was given latex 1 and one group was given comparative example 1 and the remaining one group was given comparative example 2 for continuous use for 2 months. The average value and variation of the brightness were obtained. The results are shown in Table 1. At the same time, each subject was asked a questionnaire and asked if the skin dullness had improved. Responses were significantly improved (score 5), clearly improved (score 4), slightly improved (score 3), unchanged (score 2), slightly worse (score 1), worse (score 0) And I had you answer as a score. The results are also shown in Table 1. It can be seen that there is a good correlation between the recognition of dullness improvement and the average value and variation of luminance.
I)
Tri (caprylic acid / capric acid) glycerin 3.5 parts by mass cetyl isooctanoate 2.5 parts by mass pentaerythritol tetraisooctanoate 1.5 parts by mass squalane 4 parts by mass dimethicone 1 part by mass sorbitan monostearate 1 part by mass poly Oxyethylene (150) stearate 1 part by mass polyoxybutylene polyglycerol stearyl 0.5 parts by mass b)
1,3-butanediol 6 parts by mass 1,2-pentanediol 2 parts by mass glycerin 10 parts by mass acrylic acid / alkyl acrylate (C10-30)
Copolymer (10% aqueous solution) 0.2 part by mass extract 2 0.1 part by mass extract 5 0.1 part by mass extract 7 0.1 part by mass 1% α-glycosyl hesperidin aqueous solution 0.1 part by mass phenoxyethanol 3 parts by weight water 50 parts by weight c)
10% potassium hydroxide 0.1 parts by weight Water 16 parts by weight

Like Example 1, according to the following prescription, the emulsion 2 which is the cosmetic of the present invention was prepared. Table 2 shows the results of evaluating this in the same manner as in Example 1. From this, it can be seen that the use of the extract 2 is preferable to the extract 1 in the present invention.
I)
Tri (caprylic acid / capric acid) glycerin 3.5 parts by mass cetyl isooctanoate 2.5 parts by mass pentaerythritol tetraisooctanoate 1.5 parts by mass squalane 4 parts by mass dimethicone 1 part by mass sorbitan monostearate 1 part by mass poly Oxyethylene (150) stearate 1 part by mass polyoxybutylene polyglycerol stearyl 0.5 parts by mass b)
1,3-butanediol 6 parts by mass 1,2-pentanediol 2 parts by mass glycerin 10 parts by mass acrylic acid / alkyl acrylate (C10-30)
Copolymer (10% aqueous solution) 0.2 part by weight extract 1 0.1 part by weight extract 5 0.1 part by weight extract 7 0.1 part by weight 1% α-glycosyl hesperidin aqueous solution 0.1 part by weight phenoxyethanol 0. 3 parts by weight water 50 parts by weight c)
10% potassium hydroxide 0.1 parts by weight Water 16 parts by weight

Like Example 1, according to the following prescription, the emulsion 3 which is the cosmetics of the present invention was prepared. Table 3 shows the results of evaluation of this as in Example 1. From this, it can be seen that the use of the extract 2 is preferable to the extract 3 in the present invention.
I)
Tri (caprylic acid / capric acid) glycerin 3.5 parts by mass cetyl isooctanoate 2.5 parts by mass pentaerythritol tetraisooctanoate 1.5 parts by mass squalane 4 parts by mass dimethicone 1 part by mass sorbitan monostearate 1 part by mass poly Oxyethylene (150) stearate 1 part by mass polyoxybutylene polyglycerol stearyl 0.5 parts by mass b)
1,3-butanediol 6 parts by mass 1,2-pentanediol 2 parts by mass glycerin 10 parts by mass acrylic acid / alkyl acrylate (C10-30)
Copolymer (10% aqueous solution) 0.2 part by weight extract 3 0.1 part by weight extract 5 0.1 part by weight extract 7 0.1 part by weight 1% α-glycosyl hesperidin aqueous solution 0.1 part by weight phenoxyethanol 0. 3 parts by weight water 50 parts by weight c)
10% potassium hydroxide 0.1 parts by weight Water 16 parts by weight

Like Example 1, according to the following prescription, the emulsion 4 which is the cosmetic of the present invention was prepared. Table 4 shows the results of evaluating this in the same manner as in Example 1. From this, it can be seen that the use of the extract 5 is preferable to the extract 4 in the present invention.
I)
Tri (caprylic acid / capric acid) glycerin 3.5 parts by mass cetyl isooctanoate 2.5 parts by mass pentaerythritol tetraisooctanoate 1.5 parts by mass squalane 4 parts by mass dimethicone 1 part by mass sorbitan monostearate 1 part by mass poly Oxyethylene (150) stearate 1 part by mass polyoxybutylene polyglycerol stearyl 0.5 parts by mass b)
1,3-butanediol 6 parts by mass 1,2-pentanediol 2 parts by mass glycerin 10 parts by mass acrylic acid / alkyl acrylate (C10-30)
Copolymer (10% aqueous solution) 0.2 part by mass extract 2 0.1 part by mass extract 4 0.1 part by mass extract 7 0.1 part by mass 1% α-glycosyl hesperidin aqueous solution 0.1 part by mass phenoxyethanol 3 parts by weight water 50 parts by weight c)
10% potassium hydroxide 0.1 parts by weight Water 16 parts by weight

  The present invention can be applied to cosmetics that improve dullness.

Claims (8)

1) and 0.01 to 0.5 wt% Ginsenoside, 2) Hesuperiji down glycosides 0.0001 wt% and cosmetics containing the.
The cosmetic according to claim 1, wherein the ginsenoside is contained as a hydroalcoholic extract of a root of Panax ginseng. Glycosides of the Hesuperiji down, characterized in that it is α- glycosyl hesperidin, cosmetic according to claim 1 or 2.
The cosmetic according to any one of claims 1 to 3, further comprising 1 μM to 1000 μM of astilbine. The cosmetic according to claim 4, wherein the astilbin is contained as an alcoholic extract of leaves of walnut family Engelhardtiachrisolepis. Furthermore, 0.1-10 micromol of betulinic acid and / or its salt are contained, Cosmetics in any one of Claims 1-5 characterized by the above-mentioned. The cosmetic according to claim 6, wherein the betulinic acid and / or a salt thereof is contained as a hydrous alcoholic extract of Betula japonica. The cosmetic according to any one of claims 1 to 7, wherein the cosmetic is for dullness improvement.